BUPHENYL

Marca svizra · 541160 · Marca da pled · Stizzada

Inscripziun en il register

Numer da registraziun
541160
Numer da la dumonda
59129/2005
Status
Stizzada
Tip
Marca da pled
Deponida
08-11-2005
Registrada
22-12-2005
Publitgada
05-01-2006
Stizzada
04-06-2026
Motiv
Betg prolungada
Lingua da la procedura
tudestg
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Pharmazeutische Präparate.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 04-06-2026

    Stritgà, betg prolungà

    Status of protective title
    Active → Cancelled
    Cancellation date
    04.06.2026
    Cause for cancellation
    Cancellation due to non-renewal

    Published in Swissreg on 04.06.2026

  2. 03-03-2022

    Adressa dal represchentant midada

    Representative
    Patentanwälte Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich → Schaad Balass Menzl & Partner AG, Patent- und Markenanwälte, Bellerivestrasse 20, 8034 Zürich

    Published in Swissreg on 03.03.2022

  3. 04-11-2015

    Prolungà

    Published in Swissreg on 04.11.2015

  4. 17-06-2014

    Transferì

    Owner
    Ucyclyd Pharma, Inc., 8125 North Hayden Road, Scottsdale, AZ 85258, USA → Hyperion Therapeutics, Inc., 601 Gateway Boulevard, Suite 200, South San Francisco, CA 94080, USA

    Published in Swissreg on 17.06.2014

  5. 05-01-2006

    Registrà

    Published in the SOGC no. 3 of 05.01.2006

Partidas

Possessura

Hyperion Therapeutics, Inc.

601 Gateway Boulevard, Suite 200, South San Francisco, CA 94080, US

Represententa

Schaad, Balass, Menzl & Partner AG

Schaad Balass Menzl & Partner AG Patent- und Markenanwälte

Bellerivestrasse 20, 8034 Zürich

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.